NEW YORK (GenomeWeb) – A group of researchers at the University of Pennsylvania Medical School has begun a program to improve diagnostic tools for patients suffering from Parkinson's disease.

Known as the Molecular Integration in Neurological Diagnosis (MIND) initiative, the multi-department team at Penn aims to collect and sequence more than 2,500 blood samples by 2020 to develop diagnostic tools and improve treatment options for patients suffering from Parkinson's disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.